Associated Papers
Monogenic inflammatory bowel disease with STXBP2 mutations is not resolved by hematopoietic stem cell transplantation but can be alleviated via immunosuppressive drug therapy.
Fujikawa H et al.
Clinical Immunology (orlando, Fla.), 2023
Select a paper to view details